跳至主要内容
临床试验/CTRI/2017/01/007743
CTRI/2017/01/007743尚未招募4 期

Comparison of efficacy and safety of amitriptyline with gabapentin in migraine prophylaxis: randomized double blinded double dummy trial

JIPMER Intramural fund0 个研究点目标入组 164 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
164

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Migraine patients with headache frequency >4/month (diagnosed based on International Headache Society Criteria 3).
  • 2. Migraine patients between 18 and 60 years of age, either gender.

排除标准

  • A. Patients who have received any prophylactic medication for migraine during last 1 month.
  • B. Patients with history of drug allergy.
  • C. Uncontrolled hypertension, coronary artery disease.
  • D. Pregnancy, menstrual irregularity.
  • E. Liver or kidney dysfunction.
  • F. Systemic or psychiatric disease.
  • G. Malignancy.
  • H. Those unwilling to participate in study

研究者

发起方
JIPMER Intramural fund

相似试验

Comparing amitriptyline and gabapentin in migraine... | 临床试验